Similar articles for PMID: 16061764

Year	Number of Results
1997	1
1998	1
1999	4
2000	3
2001	5
2002	1
2003	4
2004	13
2005	5
2006	7
2007	10
2008	8
2009	10
2010	4
2011	6
2012	10
2013	11
2014	10
2015	10
2016	5
2017	9
2018	5
2019	9
2020	4
2021	5
2022	5
2023	4
2024	0

1

Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.

Revicki DA, Siddique J, Frank L, Chung JY, Green BL, Krupnick J, Prasad M, Miranda J. Revicki DA, et al. Arch Gen Psychiatry. 2005 Aug;62(8):868-75. doi: 10.1001/archpsyc.62.8.868. Arch Gen Psychiatry. 2005. PMID: 16061764 Clinical Trial.

2

A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.

Doyle JJ, Casciano J, Arikian S, Tarride JE, Gonzalez MA, Casciano R. Doyle JJ, et al. Value Health. 2001 Jan-Feb;4(1):16-31. doi: 10.1046/j.1524-4733.2001.004001016.x. Value Health. 2001. PMID: 11704969 Free article.

3

A budget-impact and cost-effectiveness model for second-line treatment of major depression.

Malone DC. Malone DC. J Manag Care Pharm. 2007 Jul;13(6 Suppl A):S8-18. doi: 10.18553/jmcp.2007.13.s6-a.8. J Manag Care Pharm. 2007. PMID: 17874482 Free PMC article.

4

Treating depression in predominantly low-income young minority women: a randomized controlled trial.

Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T. Miranda J, et al. JAMA. 2003 Jul 2;290(1):57-65. doi: 10.1001/jama.290.1.57. JAMA. 2003. PMID: 12837712 Clinical Trial.

5

The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.

Ross EL, Vijan S, Miller EM, Valenstein M, Zivin K. Ross EL, et al. Ann Intern Med. 2019 Dec 3;171(11):785-795. doi: 10.7326/M18-1480. Epub 2019 Oct 29. Ann Intern Med. 2019. PMID: 31658472 Free PMC article.

6

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G. Wiles N, et al. Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310. Health Technol Assess. 2014. PMID: 24824481 Free PMC article. Clinical Trial.

7

Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

Trivedi MH, Wan GJ, Mallick R, Chen J, Casciano R, Geissler EC, Panish JM. Trivedi MH, et al. J Clin Psychopharmacol. 2004 Oct;24(5):497-506. doi: 10.1097/01.jcp.0000138769.61600.e4. J Clin Psychopharmacol. 2004. PMID: 15349005

8

Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.

Lynch FL, Dickerson JF, Clarke G, Vitiello B, Porta G, Wagner KD, Emslie G, Asarnow JR Jr, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes T, DeBar L, McCracken JT, Strober M, Suddath RL, Spirito A, Onorato M, Zelazny J, Iyengar S, Brent D. Lynch FL, et al. Arch Gen Psychiatry. 2011 Mar;68(3):253-62. doi: 10.1001/archgenpsychiatry.2011.9. Arch Gen Psychiatry. 2011. PMID: 21383263 Free PMC article. Clinical Trial.

9

Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.

Poret AW, Neslusan C, Ricci JF, Wang S, Khan ZM, Kwong JW. Poret AW, et al. Value Health. 2001 Sep-Oct;4(5):362-9. doi: 10.1046/j.1524-4733.2001.45068.x. Value Health. 2001. PMID: 11705126 Free article.

10

Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression.

Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L, Ford C, Breen S, Goodyer I. Byford S, et al. Br J Psychiatry. 2007 Dec;191:521-7. doi: 10.1192/bjp.bp.107.038984. Br J Psychiatry. 2007. PMID: 18055956 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year